{"transactions":[{"id":692924,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-07T13:18:41.000Z","date":"2026-08-05","kind":"sale","planned":false,"acquired":false,"shares":3564,"price":38.8,"value":138283.2,"ownership":{"direct":true},"balance_after":22809,"source":{"system":"sec-edgar","filing":"0001566083-26-000006","document":"wk-form4_1786108718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000156608326000006/wk-form4_1786108718.xml","form_type":"4"}},{"id":747849,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:11:22.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":29334,"source":{"system":"sec-edgar","filing":"0001484612-26-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000034/edgardoc.xml","form_type":"4"}},{"id":765574,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T12:57:14.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":28.65,"value":85950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $28.60 to $28.76 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26373,"source":{"system":"sec-edgar","filing":"0001566083-26-000004","document":"wk-form4_1779454631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000156608326000004/wk-form4_1779454631.xml","form_type":"4"}},{"id":769706,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T16:44:18.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":6144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":29373,"source":{"system":"sec-edgar","filing":"0001566083-26-000002","document":"wk-form4_1779295456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000156608326000002/wk-form4_1779295456.xml","form_type":"4"}},{"id":904722,"issuer":{"id":5950,"kind":"organization","name":"Embecta Corp.","symbol":"EMBC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-13T23:25:09.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":22841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends."}],"balance_after":64581.208,"source":{"system":"sec-edgar","filing":"0000947871-26-000162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000094787126000162/ownership.xml","form_type":"4"}},{"id":940972,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-12T21:25:08.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":18667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted to the reporting person on January 9, 2026.  Each RSU represents a contingent right to receive one share of common stock.  These RSUs shall vest quarterly over three years, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":18667,"source":{"system":"sec-edgar","filing":"0001484612-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000007/edgardoc.xml","form_type":"4"}},{"id":1138802,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:42:41.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":5401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":23229,"source":{"system":"sec-edgar","filing":"0001323885-25-000063","document":"wk-form4_1747860154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000063/wk-form4_1747860154.xml","form_type":"4"}},{"id":1179404,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T16:30:29.000Z","date":"2025-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33948,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus (\"Merger Sub\"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the \"Merger Consideration\"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-050472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000095017025050472/ownership.xml","form_type":"4"}},{"id":1217036,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T13:21:26.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":6100,"price":38.12,"value":232532.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $37.60 to $38.52 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17828,"source":{"system":"sec-edgar","filing":"0001323885-25-000027","document":"wk-form4_1741353680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000027/wk-form4_1741353680.xml","form_type":"4"}},{"id":1266734,"issuer":{"id":5950,"kind":"organization","name":"Embecta Corp.","symbol":"EMBC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-14T23:26:32.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":13839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends."}],"balance_after":39743.197,"source":{"system":"sec-edgar","filing":"0000947871-25-000188","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000094787125000188/ownership.xml","form_type":"4"}},{"id":1500294,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-28T18:55:08.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":19169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 23, 2024 or (ii) the next Annual Meeting following May 23, 2024, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,169 RSUs."}],"balance_after":33948,"source":{"system":"sec-edgar","filing":"0001610717-24-000263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071724000263/form4.xml","form_type":"4"}},{"id":1517146,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:04:26.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":7788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":23928,"source":{"system":"sec-edgar","filing":"0001323885-24-000078","document":"wk-form4_1715720654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388524000078/wk-form4_1715720654.xml","form_type":"4"}},{"id":1651246,"issuer":{"id":5950,"kind":"organization","name":"Embecta Corp.","symbol":"EMBC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T23:08:00.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":11455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends."}],"balance_after":24897.902,"source":{"system":"sec-edgar","filing":"0000947871-24-000106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000094787124000106/ownership.xml","form_type":"4"}},{"id":1824668,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-21T20:02:17.000Z","date":"2023-07-21","kind":"sale","planned":false,"acquired":false,"shares":37600,"price":0.051,"value":1917.6,"ownership":{"direct":true},"balance_after":8799,"source":{"system":"sec-edgar","filing":"0001628280-23-025327","document":"wk-form4_1689969730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000162828023025327/wk-form4_1689969730.xml","form_type":"4"}},{"id":1824667,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-21T20:02:17.000Z","date":"2023-07-19","kind":"sale","planned":false,"acquired":false,"shares":91866,"price":0.075,"value":6889.95,"ownership":{"direct":true},"balance_after":46399,"source":{"system":"sec-edgar","filing":"0001628280-23-025327","document":"wk-form4_1689969730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000162828023025327/wk-form4_1689969730.xml","form_type":"4"}},{"id":1858496,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T12:59:20.000Z","date":"2023-06-08","kind":"sale","planned":false,"acquired":false,"shares":713,"price":47.89,"value":34145.57,"ownership":{"direct":true},"balance_after":16140,"source":{"system":"sec-edgar","filing":"0001323885-23-000075","document":"wk-form4_1686574751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388523000075/wk-form4_1686574751.xml","form_type":"4"}},{"id":1874728,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-30T17:15:57.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":6754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2023 or (ii) the next Annual Meeting following May 25, 2023, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,754 RSUs."}],"balance_after":14779,"source":{"system":"sec-edgar","filing":"0001610717-23-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071723000074/form4.xml","form_type":"4"}},{"id":1876102,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T20:25:57.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":3186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":16853,"source":{"system":"sec-edgar","filing":"0001323885-23-000065","document":"wk-form4_1685132734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388523000065/wk-form4_1685132734.xml","form_type":"4"}},{"id":2022252,"issuer":{"id":5950,"kind":"organization","name":"Embecta Corp.","symbol":"EMBC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-10T21:09:17.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":6979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares reported in Column 5 of Table I now includes 65.822912 shares received by the reporting person as stock dividends."}],"balance_after":13068.8229,"source":{"system":"sec-edgar","filing":"0001209191-23-008327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000120919123008327/doc4.xml","form_type":"4"}},{"id":2231108,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T20:09:31.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":54511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on June 13, 2023, subject to the Reporting Person remaining a service provider through such date."}],"balance_after":138265,"source":{"system":"sec-edgar","filing":"0001628280-22-017225","document":"wf-form4_165532375303884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000162828022017225/wf-form4_165532375303884.xml","form_type":"4"}},{"id":2253289,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:59:21.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":4155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 26, 2022 or (ii) the next Annual Meeting following May 26, 2022, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,056 RSUs."}],"balance_after":8025,"source":{"system":"sec-edgar","filing":"0001567619-22-011887","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761922011887/doc1.xml","form_type":"4"}},{"id":2252943,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T13:03:33.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":13667,"source":{"system":"sec-edgar","filing":"0001323885-22-000074","document":"wf-form4_165365659896970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388522000074/wf-form4_165365659896970.xml","form_type":"4"}},{"id":2273136,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T10:05:32.000Z","date":"2022-05-10","kind":"purchase","acquired":true,"shares":26300,"price":2.66,"value":69958.0,"ownership":{"direct":true},"balance_after":83754,"source":{"system":"sec-edgar","filing":"0001628280-22-013939","document":"wf-form4_165234990590541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000162828022013939/wf-form4_165234990590541.xml","form_type":"4"}},{"id":2273135,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T10:05:32.000Z","date":"2022-05-10","kind":"purchase","acquired":true,"shares":10000,"price":2.6592,"value":26592.0,"ownership":{"direct":true},"balance_after":57454,"source":{"system":"sec-edgar","filing":"0001628280-22-013939","document":"wf-form4_165234990590541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000162828022013939/wf-form4_165234990590541.xml","form_type":"4"}},{"id":2273134,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T10:05:32.000Z","date":"2022-05-10","kind":"purchase","acquired":true,"shares":1300,"price":2.655,"value":3451.5,"ownership":{"direct":true},"balance_after":47454,"source":{"system":"sec-edgar","filing":"0001628280-22-013939","document":"wf-form4_165234990590541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000162828022013939/wf-form4_165234990590541.xml","form_type":"4"}},{"id":2303545,"issuer":{"id":5950,"kind":"organization","name":"Embecta Corp.","symbol":"EMBC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:38:12.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6024,"source":{"system":"sec-edgar","filing":"0001209191-22-023212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000120919122023212/doc4.xml","form_type":"4"}},{"id":2640487,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T20:32:47.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":26395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are RSUs and 1/36th of the RSUs shall vest on each monthly anniversary measured from July 1, 2021 (the \"Vesting Commencement Date\"), such that 100% of the RSUs will be fully vested on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each such vesting date."}],"balance_after":46154,"source":{"system":"sec-edgar","filing":"0001209191-21-045486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000120919121045486/doc4.xml","form_type":"4"}},{"id":2665612,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T20:25:51.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":19759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on June 14, 2022, subject to the Reporting Person remaining a service provider through such date."}],"balance_after":19759,"source":{"system":"sec-edgar","filing":"0001209191-21-040912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566083/000120919121040912/doc4.xml","form_type":"4"}},{"id":2688351,"issuer":{"id":138805,"kind":"organization","name":"CANTEL MEDICAL CORP","symbol":"CMD"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.10 per share","published_at":"2021-06-02T17:27:18.000Z","date":"2021-06-02","kind":"disposition_to_issuer","acquired":false,"shares":1935,"price":80.59,"value":155941.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the \"Merger Agreement\"), by and among Cantel Medical Corp., a Delaware corporation (the \"Company\"), STERIS plc, an Irish public limited company (\"STERIS\"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the \"Effective Time\"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the \"Stock Consideration\"), and (ii) $16.93 in cash (the \"Cash Consideration\" and, together with the Stock Consideration, the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Based on the closing price of ordinaryshares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, parvalue $.10 per share, of the Company (\"Company Common Stock\") was $63.66, and the value of the Merger Consideration payable per share of CompanyCommon Stock pursuant to the Merger Agreement was $80.59."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the \"Merger Agreement\"), by and among Cantel Medical Corp., a Delaware corporation (the \"Company\"), STERIS plc, an Irish public limited company (\"STERIS\"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the \"Effective Time\"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the \"Stock Consideration\"), and (ii) $16.93 in cash (the \"Cash Consideration\" and, together with the Stock Consideration, the \"Merger Consideration\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Based on the closing price of ordinaryshares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, parvalue $.10 per share, of the Company (\"Company Common Stock\") was $63.66, and the value of the Merger Consideration payable per share of CompanyCommon Stock pursuant to the Merger Agreement was $80.59."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the \"Merger Agreement\"), by and among Cantel Medical Corp., a Delaware corporation (the \"Company\"), STERIS plc, an Irish public limited company (\"STERIS\"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the \"Effective Time\"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the \"Stock Consideration\"), and (ii) $16.93 in cash (the \"Cash Consideration\" and, together with the Stock Consideration, the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Based on the closing price of ordinaryshares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, parvalue $.10 per share, of the Company (\"Company Common Stock\") was $63.66, and the value of the Merger Consideration payable per share of CompanyCommon Stock pursuant to the Merger Agreement was $80.59."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-075860","document":"tm2118222-14_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19446/000110465921075860/tm2118222-14_4seq1.xml","form_type":"4"}},{"id":2695016,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T21:01:50.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":1167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2021 or (ii) the next Annual Meeting following May 25, 2021, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,969 RSUs."}],"balance_after":3870,"source":{"system":"sec-edgar","filing":"0001567619-21-011223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761921011223/doc1.xml","form_type":"4"}},{"id":2698441,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T20:52:16.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":10103,"source":{"system":"sec-edgar","filing":"0001209191-21-035362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919121035362/doc4.xml","form_type":"4"}},{"id":3073162,"issuer":{"id":138805,"kind":"organization","name":"CANTEL MEDICAL CORP","symbol":"CMD"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.10 per share","published_at":"2020-07-31T17:53:55.000Z","date":"2020-07-31","kind":"grant","acquired":true,"shares":1935,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1935,"source":{"system":"sec-edgar","filing":"0000019446-20-000042","document":"wf-form4_159623241881673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19446/000001944620000042/wf-form4_159623241881673.xml","form_type":"4"}},{"id":3136763,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T12:28:15.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":2452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":8354,"source":{"system":"sec-edgar","filing":"0001209191-20-031562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919120031562/doc4.xml","form_type":"4"}},{"id":3336753,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-18T16:31:17.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":2703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on December 17 of each year, beginning December 17, 2020, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,703 RSUs."}],"balance_after":2703,"source":{"system":"sec-edgar","filing":"0001567619-19-023321","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919023321/doc1.xml","form_type":"4"}},{"id":3350673,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T21:24:08.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":5902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant."}],"balance_after":5902,"source":{"system":"sec-edgar","filing":"0001209191-19-059298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919119059298/doc4.xml","form_type":"4"}},{"id":4012378,"issuer":{"id":3536,"kind":"organization","name":"HENRY SCHEIN INC","symbol":"HSIC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP&CEO Gl.AH.Med.Den.Sur.Grp"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-06T21:23:26.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":19558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (RSU) pursuant to the Issuer's 2013 Stock Incentive Plan. Subject to certain exceptions, 65% will vest subject to (x) Issuer's achievement of a specified performance goal and (y) reporting person's continued perf. of services for the Issuer. 35% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued perf. of services for the Issuer. With respect to the performance-based RSU, if the continued service requirement is satisfied and achievement of the performance goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved that is below 100% of target (shortfall)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 14, 2017, the common stock of Henry Schein, Inc. split two-for-one (for shares held on the record date of September 1, 2017), resulting in the reporting person's ownership of additional shares of common stock."}],"balance_after":62902,"source":{"system":"sec-edgar","filing":"0001209191-18-017240","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000228/000120919118017240/doc4.xml","form_type":"4"}},{"id":4395699,"issuer":{"id":3536,"kind":"organization","name":"HENRY SCHEIN INC","symbol":"HSIC"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP&CEO Gl.AH.Med.Den.Sur.Grp"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-03-08T21:25:34.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":8777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock (RS) pursuant to the Issuer's 2013 Stock Incentive Plan. Subject to certain exceptions, 65% will vest subject to (x) Issuer's achievement of a specified performance goal and (y) reporting person's continued perf. of services for the Issuer. 35% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued perf. of services for the Issuer. With respect to the performance-based RS, if the continued service requirement is satisfied and achievement of the performance goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved that is below 100% of target (i.e., shortfall)."}],"balance_after":21672,"source":{"system":"sec-edgar","filing":"0001209191-17-019260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000228/000120919117019260/doc4.xml","form_type":"4"}}]}